1. Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study. Issue 1 (27th December 2021) Authors: Peled, Nir; Kian, Waleed; Inbar, Edna; Goldstein, Iris M; Zemel, Melanie; Rotem, Ofer; Rozenblum, Anna B; Nechushtan, Hovav; Dudnik, Elizabeth; Levin, Daniel; Zer, Alona; Keren-Rosenberg, Shoshana; Yust-Katz, Shlomit; Fuchs, Vered; Remilah, Areen A; Shelef, Ilan; Roisman, Laila C Journal: Neuro-oncology advances Issue: Volume 4:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗